Search Results - "Phillips, JT"
-
1
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Published in The New England journal of medicine (02-03-2006)“…This placebo-controlled, randomized trial of patients with relapsing multiple sclerosis demonstrated benefits of natalizumab (an α 4 integrin antagonist) in…”
Get full text
Journal Article -
2
Immune surveillance in multiple sclerosis patients treated with natalizumab
Published in Annals of neurology (01-05-2006)“…Objective Our objective was to test whether natalizumab, an antibody against very late activating antigen (VLA)‐4, interferes with central nervous system…”
Get full text
Journal Article -
3
Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study
Published in Neurology (23-11-2004)“…To evaluate the efficacy and safety of interferon beta-1b (IFNbeta-1b) in subjects with secondary progressive multiple sclerosis (SPMS). This 3-year,…”
Get full text
Journal Article -
4
The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Published in Neurology (09-09-2003)“…Advancements in imaging technologies and newly evolving treatments offer the promise of more effective management strategies for MS. Until recently,…”
Get full text
Journal Article -
5
P2-12-32: Association between Progranulin (GP88) Expression and Recurrence Risk for Breast Cancer Patients with Estrogen Receptor Positive Invasive Ductal Carcinoma
Published in Cancer research (Chicago, Ill.) (15-12-2011)“…Abstract Purpose: GP88 (progranulin) is a critical player of breast tumorigenesis for estrogen receptor positive (ER+) breast cancer. Pathological studies…”
Get full text
Journal Article -
6
Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients
Published in Multiple sclerosis (01-03-2011)“…Background: We aimed to evaluate effects of gender on efficacy and safety of intramuscular (IM) interferon beta (IFNβ)-1a in patients with relapsing–remitting…”
Get full text
Journal Article -
7
A clinical therapeutic trial of cyclosporine in myasthenia gravis
Published in Annals of the New York Academy of Sciences (21-06-1993)“…We randomly assigned 39 patients with steroid-dependent generalized myasthenia gravis to treatment with cyclosporine (5 mg/kg per body weight in divided doses)…”
Get more information
Journal Article -
8
An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis
Published in Multiple sclerosis (01-10-2004)“…In this open-label drug-interaction trial, we studied 38 patients with relapsing-remitting multiple sclerosis (MS) who received 3.0 or 6.0 mg/kg of natalizumab…”
Get full text
Journal Article -
9
Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
Published in Multiple sclerosis (01-06-2004)“…Background: The objective for this article is to highlight some of the adverse skin manifestations associated with injectable disease modifying therapy for…”
Get full text
Journal Article -
10
Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score
Published in Journal of neurology, neurosurgery and psychiatry (01-07-2002)“…Background: There is a poor correlation between multiple sclerosis disease activity, as measured by magnetic resonance imaging, and clinical disability…”
Get full text
Journal Article -
11
A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of avonex in patients with multiple sclerosis
Published in Clinical therapeutics (01-04-2004)“…Background: A new liquid formulation of Avonex (interferon beta-1a [IFNβ-1a]) in a prefilled syringe has been developed to make administration of the drug…”
Get full text
Journal Article -
12
Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions
Published in Archives of neurology (Chicago) (01-09-2005)“…Major advancements have been achieved in our ability to diagnose multiple sclerosis (MS) and to commence treatment intervention with agents that can favorably…”
Get more information
Journal Article -
13
The utility of MRI in suspected MS: report of the Therapeutics and technology assessment Subcommittee of the American Academy of Neurology
Published in American journal of ophthalmology (01-02-2004)“…[...]the presence of two or more gadolinium (Gd)-enhancing lesions at baseline and the appearance of either new T2 lesions or new Gd enhancement on follow-up…”
Get full text
Journal Article -
14
Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis
Published in The New England journal of medicine (19-03-1987)“…We randomly assigned 20 patients with progressively worsening generalized myasthenia gravis of recent onset whose illness was not controlled by…”
Get more information
Journal Article -
15
Prolactin Stimulates Proliferation of Cultured Human Keratinocytes
Published in Journal of investigative dermatology (01-09-1993)“…The effect of the pituitary hormone prolactin on in vitro proliferation of human keratinocytes has been studied. Cell proliferation was determined by [3H]…”
Get full text
Journal Article Conference Proceeding -
16
Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons
Published in Journal of interferon & cytokine research (01-02-1995)“…The effect of orally administered type 1 interferons on the severity of acute experimental autoimmune encephalomyelitis (EAE), a T cell-mediated autoimmune…”
Get more information
Journal Article -
17
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations
Published in Archives of neurology (Chicago) (01-10-2005)“…In the management of patients with multiple sclerosis (MS), providers are all faced with the highly formidable challenge of ascertaining whether, and to what…”
Get more information
Journal Article -
18
Prolactin receptor expression by lymphoid tissues in normal and immunized rats
Published in Molecular and cellular endocrinology (01-04-1993)“…Prolactin receptor (PRLr) expression and distribution in thymus, spleen, bone marrow, lymph nodes, and peripheral blood lymphocytes from young adult Lewis rats…”
Get more information
Journal Article -
19
Rethinking multiple sclerosis
Published in Archives of neurology (Chicago) (01-01-2001)Get more information
Journal Article -
20